- A translational study case report on the small molecule energy blocker 3-bromopyruvate – 3BP – as a potent anticander agent – from bench to bedsite.
- Case Report: Sodium dichloroacetate (DCA) inhibition of the “Warburg Effect” in a human cancer patient: complete response in non-Hodgkin’s lymphoma after disease progression with rituximab-CHOP
- Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate
- 2-Deoxy-D-Glucose Treatment Induces Ketogenesis, Sustains Mitochondrial Function, and Reduces Pathology in Female Mouse Model of Alzheimer’s Disease
- Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
- Toxicological Review of Dichloroacetic Acid
- Two cases of malignant tumors with metastases apparently treated successfully with hypoglycemic coma
- Metformin is synthetically lethal with glucose withdrawal in cancer cells
- Metabolic Modulation of Glioblastoma with Dichloroacetate
- Anticancer drugs that target metabolism: is dichloroacetate the new paradigm?
- Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
- Published-Studies-Sodium-Phenylbutyrate
- Selective Activity of Phenylacetate against Malignant Gliomas: Resemblance to Fetal Brain Damage in Phenylketonuria
- Selective Growth Arrest and Phenotypic Reversion of Prostate Cancer Cells In Vitro by Nontoxic Pharmacological Concentrations of Phenylacetate
- Phenylacetate: A Novel Nontoxic Inducer of Tumor Cell Differentiation
- Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells
Metabolic Therapy for Cancer (Drugs)
Reply